StemCells Inc. (STEM) said it transplanted neural stem cells into its first patient with dry age-related macular degeneration, pushing forward its Phase I/II clinical trial.
View the original article here: StemCells Transplants Stem Cells into 1st Macular-Degeneration Patient – Wall Street Journal